Role of Nutraceuticals in Metabolic Disorders: Mechanisms and Benefits
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Nutrition and Metabolism".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 1004
Special Issue Editor
Special Issue Information
Dear Colleagues,
Metabolic disorders include a range of ailments that provide a substantial challenge to worldwide healthcare systems, encompassing major diseases, such as obesity, type 2 diabetes, dyslipidemia, and hypertension. These disorders not only significantly contribute to the rates of illness and death worldwide but they also have extensive socioeconomic consequences that restrict the quality of life for millions of people around the world. Modifications to one's diet and level of physical activity are thus not only suggested but also absolutely necessary in the prevention and treatment of these diseases. It has been shown that therapies based on lifestyle, such as maintaining a healthy balanced diet and engaging in regular physical exercise, may greatly lessen the burden of metabolic diseases by treating not just their symptoms but also the underlying causes of these conditions. In view of the fact that conventional treatments have only been somewhat successful in the treatment of complicated metabolic diseases, nutraceutical interventions have become more popular as viable alternatives. Nutraceuticals (such as polyphenols and resveratrol) and antioxidants (such as vitamins C and E) have been shown to decrease oxidative stress in metabolic disorders. Nutraceuticals and other similar products represent the future of utilizing natural substances derived from plants and animals to maximize the productivity of natural resources and promote sustainability within the circular economy. This is particularly important for countries with abundant raw materials, as their utilization must be cost-effective. It is crucial to reiterate the significance of innovative therapeutic approaches and accurate medication formulations. Hence, it is crucial to encourage research endeavors that focus on enhancing the bioavailability of nutraceuticals and tailoring therapies to individual genetic and metabolic factors.
Preference is given to manuscripts that promote inter- and/or transdisciplinary research by applying innovative conceptual thoughts to theoretical models, existing methodologies, and strategy applications. In addition, innovations pertaining to the Sustainable Development Goals and potential impacts of nutraceuticals on metabolism pathways are of specific importance, as long as they highlight general or distinct efforts and identify current gaps in the health impacts of various diseases, such as diabetes, obesity, etc., as well as strategies for addressing them. We welcome articles based on original research, systematic reviews, or methodological advances.
The scope of this research extends beyond the specific areas stated below:
Topic 1: Metabolic syndrome: an analysis of global epidemiology.
Topic 2: Functional foods as potential new therapeutic aims.
Theme 3: Nutraceuticals: their present use and future prospects.
Theme 4: Investigating the role of nutraceuticals in metabolic disorders and their mechanisms of action.
Theme 5: Evolution of pharmacological practices based on nutraceuticals on metabolic disorders.
Dr. Susmita Barman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nutraceuticals
- functional foods
- metabolic syndrome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
